Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

C.R. Bard (BCR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,293,508
  • Shares Outstanding, K 72,890
  • Annual Sales, $ 3,714 M
  • Annual Income, $ 531,400 K
  • 36-Month Beta 0.53
  • Price/Sales 6.55
  • Price/Cash Flow 24.76
  • Price/Book 12.05

Price Performance

See More
Period Period Low Period High Performance
1-Month
325.31 +2.45%
on 11/01/17
335.84 -0.76%
on 11/03/17
+3.13 (+0.95%)
since 10/20/17
3-Month
317.34 +5.03%
on 09/22/17
335.84 -0.76%
on 11/03/17
+15.09 (+4.74%)
since 08/18/17
52-Week
206.26 +61.59%
on 12/01/16
335.84 -0.76%
on 11/03/17
+117.56 (+54.49%)
since 11/18/16

Most Recent Stories

More News
Featured Company News - Merit Medical Signs Agreement with Becton, Dickinson & Co. to Acquire Divestment Assets

LONDON, UK / ACCESSWIRE / November 20, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Merit Medical Systems, Inc. (NASDAQ: MMSI) ("Merit"), following...

BCR : 333.29 (-0.08%)
MMSI : 41.90 (+3.20%)
BDX : 221.50 (+0.54%)
MDSY : 0.73 (+4.29%)
BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's announcement by Merit Medical Systems, Inc. that it has signed...

BCR : 333.29 (-0.08%)
BDX : 221.50 (+0.54%)
MDSY : 0.73 (+4.29%)
Merit Medical Signs Purchase Agreement with BD for Divestment Assets

Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology,...

BCR : 333.29 (-0.08%)
MMSI : 41.90 (+3.20%)
Technical Snapshots for These Medical Supplies Stocks -- Microbot Medical, C.R. Bard, Cooper Cos., and Waters

If you want a Stock Review on MBOT, BCR, COO, or WAT then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. DailyStockTracker.com has redirected investors'...

BCR : 333.29 (-0.08%)
COO : 239.94 (+0.54%)
WAT : 200.27 (+1.04%)
MBOT : 1.22 (+8.93%)
Earnings Review and Free Research Report: C.R. Bard's Revenue Grew 5%; Adjusted EPS Increased 14.3%

Research Desk Line-up: DENTSPLY SIRONA Post Earnings Coverage

BCR : 333.29 (-0.08%)
XRAY : 66.43 (-1.66%)
Corporate News Blog - Medical Technology Company Pulse Biosciences Announces Changes to its Board

Research Desk Line-up: C. R. Bard Post Earnings Coverage

BCR : 333.29 (-0.08%)
PLSE : 25.94 (+4.30%)
ABBV : 93.60 (-0.01%)
MedTech Growing on Emerging Markets, M&A: Stocks to Buy

MedTech Growing on Emerging Markets, M&A: Stocks to Buy

VIVO : 14.85 (-0.67%)
SYK : 154.75 (-0.42%)
TRUMY : 44.2500 (+1.51%)
STE : 88.14 (+0.33%)
BSX : 28.35 (+0.32%)
NXTM : 25.90 (-0.35%)
JNJ : 137.93 (-0.05%)
RMD : 84.71 (+0.09%)
LMNX : 21.54 (+0.14%)
NEOG : 81.71 (+1.65%)
FMS : 48.59 (-0.49%)
CSII : 24.62 (+0.98%)
BCR : 333.29 (-0.08%)
HOLX : 40.19 (+0.58%)
DXTR : 0.16 (unch)
CYH : 3.99 (-3.86%)
ABT : 55.29 (-0.49%)
NUVA : 55.48 (-3.16%)
BDX : 221.50 (+0.54%)
MDT : 78.90 (-0.74%)
OCPNY : 40.2800 (+0.75%)
Bard Announces Third Quarter Results

C. R. Bard, Inc. (NYSE: BCR) today reported 2017 third quarter financial results. The company has included supplemental financial data on its website related to this earnings release. Third...

BCR : 333.29 (-0.08%)
Research Report Identifies Sherwin-Williams, Charter Communications, Biogen, C. R. Bard, Mohawk Industries, and Humana Inc. with Renewed Outlook - Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Sherwin-Williams Company...

BCR : 333.29 (-0.08%)
MHK : 276.74 (+1.67%)
HUM : 233.48 (+0.01%)
SHW : 387.69 (+0.18%)
CHTR : 338.37 (-0.93%)
BIIB : 309.46 (-1.44%)
EW vs. BCR: Which Stock is Poised for Better Q3 Earnings?

Political turmoil and the health policy related battle apart, majority of the MedTech stocks' bottom line is likely to be hurt in the third quarter on escalating costs induced by consecutive hurricanes...

BCR : 333.29 (-0.08%)
EW : 107.16 (+0.07%)
BSX : 28.35 (+0.32%)
BDX : 221.50 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair,...

See More

Key Turning Points

2nd Resistance Point 334.65
1st Resistance Point 333.97
Last Price 333.29
1st Support Level 332.95
2nd Support Level 332.61

See More

52-Week High 335.84
Last Price 333.29
Fibonacci 61.8% 286.34
Fibonacci 50% 271.05
Fibonacci 38.2% 255.76
52-Week Low 206.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart